Teacher Retirement System of Texas bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 17,236 shares of the company's stock, valued at approximately $387,000.
Several other hedge funds and other institutional investors have also bought and sold shares of PRVA. Bessemer Group Inc. boosted its holdings in Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after acquiring an additional 2,178 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in shares of Privia Health Group by 4.6% during the first quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company's stock valued at $1,243,000 after buying an additional 2,413 shares during the period. PNC Financial Services Group Inc. boosted its holdings in Privia Health Group by 8.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock worth $140,000 after acquiring an additional 533 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after acquiring an additional 1,521 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in Privia Health Group by 10.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock valued at $27,687,000 after purchasing an additional 138,747 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.
Privia Health Group Stock Performance
Shares of PRVA traded down $1.10 during midday trading on Friday, hitting $19.61. 1,098,754 shares of the company traded hands, compared to its average volume of 768,045. The firm has a 50 day moving average of $22.54 and a 200-day moving average of $23.00. Privia Health Group, Inc. has a 52 week low of $16.47 and a 52 week high of $26.09. The stock has a market cap of $2.39 billion, a price-to-earnings ratio of 163.43, a PEG ratio of 3.14 and a beta of 0.82.
Analyst Upgrades and Downgrades
PRVA has been the subject of several recent analyst reports. Truist Financial raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Robert W. Baird increased their target price on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. Barclays lifted their target price on Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 27th. JPMorgan Chase & Co. lifted their price target on Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a report on Wednesday, May 28th. Finally, Evercore ISI cut their price objective on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research report on Wednesday, July 9th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $28.38.
Get Our Latest Research Report on PRVA
Insider Buying and Selling
In related news, Director Matthew Shawn Morris sold 10,309 shares of the company's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $240,508.97. Following the sale, the director directly owned 59,792 shares of the company's stock, valued at $1,394,947.36. This represents a 14.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Parth Mehrotra sold 15,100 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $352,283.00. Following the sale, the chief executive officer directly owned 454,281 shares in the company, valued at $10,598,375.73. This trade represents a 3.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,949 shares of company stock valued at $1,100,368. Insiders own 10.70% of the company's stock.
About Privia Health Group
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured Articles
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
